Search Results - "BESNIER, J. M."

Refine Results
  1. 1

    Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2003 by GRAMMATICO, L., BARON, S., RUSCH, E., LEPAGE, B., SURER, N., DESENCLOS, J. C., BESNIER, JM.

    Published in Epidemiology and infection (01-05-2008)
    “…Vertebral osteomyelitis (VO) is a rare event. To estimate the incidence of VO in France for 2002–2003, national hospital-discharge data were used. Hospital…”
    Get full text
    Journal Article
  2. 2

    Human-to-Human Transmission of Tuberculosis Caused by Mycobacterium bovis in Immunocompetent Patients by Sunder, S, Lanotte, P, Godreuil, S, Martin, C, Boschiroli, M.L, Besnier, J.M

    Published in Journal of Clinical Microbiology (01-04-2009)
    “…Human-to-human transmission of Mycobacterium bovis in two immunocompetent patients from the same family was confirmed by spoligotyping (pattern F35, which was…”
    Get full text
    Journal Article
  3. 3

    Optimal Duration of Antibiotic Therapy in Vertebral Osteomyelitis by Roblot, F., MD, Besnier, J.M., MD, Juhel, L., MD, Vidal, C., MD, Ragot, S., PhD, Bastides, F., MD, Le Moal, G., MD, Godet, C., MD, Mulleman, D., MD, Azaïs, I., MD, Becq-Giraudon, B., MD, Choutet, P., MD

    Published in Seminars in arthritis and rheumatism (01-04-2007)
    “…Objectives To compare the risk of relapse of vertebral osteomyelitis (VO), according to the duration of antibiotic therapy (≤6 weeks versus >6 weeks). Methods…”
    Get full text
    Journal Article
  4. 4

    Non-touch fittings in hospitals: a procedure to eradicate Pseudomonas aeruginosa contamination by van der Mee-Marquet, N., Bloc, D., Briand, L., Besnier, J.-M., Quentin, R.

    Published in The Journal of hospital infection (01-07-2005)
    “…Non-touch taps, now common in hospitals, can easily be contaminated with Pseudomonas aeruginosa. We report our experience with 87 non-touch taps in a newly…”
    Get full text
    Journal Article
  5. 5

    Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study by Roblot, F, Le Moal, G, Godet, C, Hutin, P, Texereau, M, Boyer, E, Prazuck, T, Lacroix, C, Souala, M.Faouzi, Raffi, F, Weinbreck, P, Besnier, J.M, Garo, B, de Gentile, L, Becq-Giraudon, B

    Published in The Journal of infection (01-07-2003)
    “…Objectives. A retrospective multicentric study was conducted over a five-year period to evaluate the clinical and laboratory characteristics and outcome of…”
    Get full text
    Journal Article
  6. 6

    Opportunistic infections occurring during highly active antiretroviral treatment by MICHELET, C, ARVIEUX, C, CARTIER, F, FRANCOIS, C, BESNIER, J. M, ROGEZ, J. P, BREUX, J. P, SOUALA, F, ALLAVENA, C, RAFFI, F, GARRE, M

    Published in AIDS (London) (01-10-1998)
    “…To analyse the characteristics of opportunistic infections in patients receiving highly active antiretroviral treatment (HAART). A retrospective study…”
    Get full text
    Journal Article
  7. 7

    Spread of Stenotrophomonas maltophilia colonization in a pediatric intensive care unit detected by monitoring tracheal bacterial carriage and molecular typing by Lanotte, P., Cantagrel, S., Mereghetti, L., Marchand, S., Van der Mee, N., Besnier, J.M., Laugier, J., Quentin, R.

    Published in Clinical microbiology and infection (01-11-2003)
    “…In our pediatric intensive care unit in Tours (France), intubated and ventilated inpatients are systematically monitored for tracheal bacterial colonization…”
    Get full text
    Journal Article
  8. 8

    Long‐term assessment of nevirapine‐containing highly active antiretroviral therapy in antiretroviral‐naive HIV‐infected patients: 3‐year follow‐up of the VIRGO study by Reliquet, V, Allavena, C, François‐Brunet, C, Perré, P, Bellein, V, Garré, M, May, T, Souala, F, Besnier, JM, Raffi, F

    Published in HIV medicine (01-10-2006)
    “…Objectives Data on the durability of antiretroviral regimens over a 3‐year period have only rarely been reported. The aim of this study was to evaluate the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene by TIMMERMAN, C. P, FLEER, A, BESNIER, J. M, DE GRAAF, L, CREMERS, F, VERHOEF, J

    Published in Infection and Immunity (01-11-1991)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11

    Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients by RAFFI, F, RELIQUET, V, BILLAUDEL, S, AUGER, S, BESNIER, J.-M, CHENNEBAULT, J.-M, BILLAUD, E, MICHELET, C, PERRE, P, LAFEUILLADE, A, MAY, T

    Published in AIDS (London) (22-10-1998)
    “…To assess the efficacy, tolerance, and safety of combination antiretroviral therapy with didanosine and stavudine in HIV-infected patients with CD4+ cell…”
    Get full text
    Journal Article
  12. 12

    The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults by Raffi, F, Reliquet, V, Ferré, V, Arvieux, C, Hascoet, C, Bellein, V, Besnier, J M, Breux, J P, Garré, M, May, T, Molina, J M, Perré, P, Raguin, G, Rozenbaum, W, Zucman, D

    Published in Antiviral therapy (01-12-2000)
    “…The virological and immunological efficacy of the triple regimen containing nevirapine (once or twice daily), didanosine (once daily) and stavudine, in…”
    Get full text
    Journal Article
  13. 13

    Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France by De Cock, E., Sorensen, S., Levrat, F., Besnier, J.-M., Dupon, M., Guery, B., Duttagupta, S.

    Published in Médecine et maladies infectieuses (01-05-2009)
    “…Studies have shown similar clinical cure rates and shorter length of hospitalization when using linezolid compared to vancomycin in patients with complicated…”
    Get full text
    Journal Article
  14. 14

    Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection by LEIBENGUTH, Patrice, LE GUELLEC, Chantal, BESNIER, Jean-Marc, BASTIDES, Frederic, MACE, Muriel, GAUDET, Marie-Laure, AUTRET-LECA, Elisabeth, PAINTAUD, Gilles

    Published in Therapeutic drug monitoring (01-12-2001)
    “…Published data suggest that therapeutic drug monitoring of human immunodeficiency virus protease inhibitors would improve the management of antiretroviral…”
    Get full text
    Journal Article
  15. 15

    Enzyme-linked oligosorbent assay for detection of polymerase chain reaction-amplified human immunodeficiency virus type 1 by MALLET, F, HEBRARD, C, BRAND, D, CHAPUIS, E, CROS, P, ALLIBERT, P, BESNIER, J. M, BARIN, F, MANDRAND, B

    Published in Journal of Clinical Microbiology (01-06-1993)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Medical treatment of infective endocarditis: general principles by Besnier, J M, Choutet, P

    Published in European heart journal (01-04-1995)
    “…The main objective of medical treatment of infective endocarditis is to sterilize the vegetative lesions characteristic of the disease. The general principles…”
    Get more information
    Journal Article
  17. 17

    Isolated motor control dysfunction related to progressive multifocal leukoencephalopathy during AIDS with normal MRI by DE TOFFOL, B, VIDAILHET, M, GRAY, F, BESNIER, J. M, MENAGE, P, LESCS, M. C, CHOUTET, P, AUTRET, A

    Published in Neurology (01-12-1994)
    “…We describe the case of a human immunodeficiency virus-infected 34-year-old man with progressive multifocal leukoencephalopathy (PML). His case displayed…”
    Get full text
    Journal Article
  18. 18

    Infective endocarditis due to Streptococcus suis serotype 2 by Tayoro, J, Besnier, J M, Laudat, P, Cattier, B, Choutet, P

    “…Streptococcus suis was first described in 1966 and was definitely distinguished from group D streptococci in 1987. This organism has been reported to cause…”
    Get full text
    Journal Article
  19. 19

    Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection by Turbica, Isabelle, Simon, François, Besnier, Jean Marc, LeJeune, Bernard, Choutet, Patrick, Goudeau, Alain, Barin, Francis

    Published in Journal of medical virology (01-07-1997)
    “…Our objective was to analyse the humoral response to the major neutralizing epitopes of gp120. The kinetics of the appearance of antibodies directed to the V3…”
    Get full text
    Journal Article
  20. 20

    Current predisposing factors for Pneumocystis pneumonia in immunocompromised HIV-negative patients by Roblot, F, Godet, C, Kauffmann, C, Tattevin, P, Boutoille, D, Besnier, J-M, Hauet, T, Le gericco, et

    Published in Journal de mycologie médicale (01-12-2009)
    “…A prospective study was carried out to determine the current characteristics of patients affected by pneumopathy due to Pneumocystis (PPC), to identify those…”
    Get full text
    Journal Article